SOTAC PHARMACEUTICALS LTD
Latest filings
- Routine share demat certificate filed for Q2 FY27 · Compliance
- Sotac Pharma publishes EOGM notice in newspapers; meeting on Oct 31 · Compliance
- EGM on October 31 to approve increase in authorised share capital · Board & Shareholder Meetings
Snapshot
What the business is, and whether it's a good one at a fair price.
A listed company listed on NSE.
Scorecard
Measured from the filed financials · as of FY26 — not investment advice
Strengths
Concerns
Nothing flagged in the filed numbers.Charts
How has the market priced it — with filings on the timeline?
SOTAC · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Peers
How does it stack up on valuation, returns and growth?
Loading peers…
Financials
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Ownership
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Common questions
Answered from SOTAC PHARMACEUTICALS LTD's filed financials and exchange disclosures
What does SOTAC PHARMACEUTICALS LTD do?
SOTAC PHARMACEUTICALS LTD is listed on NSE, trading under the symbol SOTAC.
Does SOTAC PHARMACEUTICALS LTD pay a dividend?
Yes. The dividend yield is 0.10% at the current price.
How much does the SOTAC PHARMACEUTICALS LTD share price move in a day?
On a typical session SOTAC PHARMACEUTICALS LTD moves 3.32% — that is the median absolute close-to-close move across its last 82 trading days. MarketPing measures each filing's price reaction against it.
Where can I track SOTAC PHARMACEUTICALS LTD's announcements?
Every NSE and BSE filing by SOTAC PHARMACEUTICALS LTD appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.